HCV Epidemiology

Medical Advocates
HCV Infection/Disease

North American Seroprevalence/Incidence Studies/
National Challenges
Canada
United States

HCV Epidemiology Main Page

Main New/Newsworthy Home Page

Last Update: April 11, 2015
Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader

Canada

Journal Papers, Abstracts, and Commentaries

Increased eligibility for treatment of chronic hepatitis C infection with shortened duration of therapy: Implications for access to care and elimination strategies in Canada.
Borgia SM, Rowaiye A.
Can J Gastroenterol Hepatol. 2015 Apr;29(3):125-9
Abstract
Visits to primary care physicians among persons who inject drugs at high risk of hepatitis C virus infection: room for improvement.
Artenie AA, Jutras-Aswad D, Roy É, et al
J Viral Hepat. 2015 Jan 14.
Abstract

Cost-effectiveness of screening for hepatitis C in Canada.
Wong WW, Tu HA, Feld JJ, et al
CMAJ. 2015 Jan 12. pii: cmaj.140711.
Abstract

Burden of disease and cost of chronic hepatitis C infection in Canada.
Myers RP, Krajden M, Bilodeau M, et al
Can J Gastroenterol Hepatol. 2014 May;28(5):243-50.
Abstract

Accuracy of physician reporting in routine public health surveillance for hepatitis C virus infection
Jochem K, Leclerc P, Maurais E, et al
Public Health Rep. 2014 Jan;129(1):64-72.
Abstract

The Second Canadian Symposium on Hepatitis C Virus: A call to action.
Grebely J, Bilodeau M, Feld JJ, et al
Can J Gastroenterol. 2013 Nov;27(11):627-32
Abstract

The epidemiology of hepatitis C in a Canadian Indigenous population.
Uhanova J, Tate RB, Tataryn DJ, Minuk GY.
Can J Gastroenterol. 2013 Jun;27(6):340-39.
Abstract

Hepatitis C Testing, Infection, and Linkage to Care Among Racial and Ethnic Minorities in the United States, 2009-2010.
Tohme RA, Xing J, Liao Y, et al
Am J Public Health. 2012 Nov 15.
Abstract

Factors associated with HCV antiviral treatment uptake among participants of a community-based HCV programme for marginalized patients.
Charlebois A, Lee L, Cooper E, et al
J Viral Hepat. 2012 Dec;19(12):836-42.
Abstract

Injection of drug residue as a potential risk factor for HCV acquisition among Montréal young injection drug users.
Roy E, Arruda N, Leclerc P, et al
Drug Alcohol Depend. 2012 Jun 12.
Abstract

FULL-TEXT ARTICLE
Transmission Patterns of HIV and Hepatitis C Virus among Networks of People Who Inject Drugs.
Pilon R, Leonard L, Kim J, et al
PLoS One. 2011;6(7):e22245
Paper

Health Utilities and Psychometric Quality of Life in Patients With Early- and Late-Stage Hepatitis C Virus Infection.
Hsu PC, Federico CA, Krajden M,
J Gastroenterol Hepatol. 2011 Jun 16
Abstract

A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel.
Cornberg M, Razavi HA, Alberti A, et al
Liver Int. 2011 Jul;31 Suppl 2:30-60.
Abstract

Health care costs associated with hepatitis C: A longitudinal cohort study.
Krajden M, Kuo M, Zagorski B, et al
Can J Gastroenterol. 2010 Dec;24(12):717-26
Abstract

Access to sterile injecting equipment is more important than awareness of HCV status for injection risk behaviors among drug users.
Cox J, Morissette C, De P, Tremblay C, et al
Subst Use Misuse. 2009;44(4):548-68
Abstract

The social production of hepatitis C risk among injecting drug users: a qualitative synthesis.
Rhodes T, Treloar C
Addiction. 2008 Oct;103(10):1593-603.
Abstract

The burden of hepatitis C virus infection is growing: A Canadian population-based study of hospitalizations from 1994 to 2004.
Myers RP, Liu M, Shaheen AA.
Can J Gastroenterol. 2008 Apr;22(4):381-7.
Abstract

The depiction of stigmatization in research about hepatitis C.
Paterson BL, Backmund M, Hirsch G, Yim C.
Int J Drug Policy. 2007 Oct;18(5):364-73.
Abstract

Everybody’s got it, but…: situational and strategic participation in normalized HCV discourse among injection drug users in Edmonton, Canada.
Wozniak L, Prakash M, Taylor M, Wild TC.
Int J Drug Policy. 2007 Oct;18(5):388-96.
Abstract

Hepatitis C meanings and preventive strategies among street-involved young injection drug users in Montréal.
Roy E, Nonn E, Haley N, Cox J.
Int J Drug Policy. 2007 Oct;18(5):397-405.
Abstract

Hepatitis C virus infection among First Nation and non-First Nation people in Manitoba, Canada a public health laboratory study.
Dawood M, Smart G, Wood M, et al
Can J Microbiol. 2006 Oct;52(10):999-1005.
Abstract

Conference Reports, Abstracts, and Posters

The Cedar Project: rapid increase of HCV infections among young Indigenous people who initiated injection of drugs in two Canadian cities
P.M. Spittal, M.T. Schechter, A. Moniruzzaman
(XVII International AIDS Conference)
Abstract

United States

     Internet Documents

INTERNET DOCUMENT
Screening for Hepatitis C Virus Infection in Adults
U.S. Preventive Services Task Force Recommendation Statement
June 25, 2013
Guidelines

     Journal Papers, Abstracts, and Commentaries

FULL-TEXT ARTICLE
Spatiotemporal Analysis of Hepatitis C Virus Infection.
Shulla A, Randall G.
PLoS Pathog. 2015 Mar 30;11(3):e1004758
Paper

Bacteremia in hemodialysis patients with hepatitis C.
Chebrolu P, Colombo RE, Baer S, et al
Am J Med Sci. 2015 Mar;349(3):217-21
Abstract

Lack of Health Insurance Limits the Benefits of Hepatitis C Virus Screening: Insights from the National Health and Nutrition Examination Hepatitis C Follow-Up Study.
Ditah I, Al Bawardy B, Gonzalez HC, et al
Am J Gastroenterol. 2015 Mar 10.
Abstract

Contextual analysis of determinants of late diagnosis of hepatitis C virus infection in Medicare patients.
Chirikov VV, Shaya FT, Howell CD.
Hepatology. 2015 Mar 7.
Abstract

FULL-TEXT ARTICLE
Transmission of hepatitis C virus associated with surgical procedures – New Jersey 2010 and Wisconsin 2011.
Apostolou A, Bartholomew ML, Greeley R et al
MMWR Morb Mortal Wkly Rep. 2015 Feb 27;64(7):165-70.
Paper

Results from a Geographically Focused, Community-Based HCV Screening, Linkage-to-Care and Patient Navigation Program.
Trooskin SB, Poceta J, Towey CM, et al.
J Gen Intern Med. 2015 Feb
Abstract

Cost-effectiveness of hepatitis C treatment for patients in early stages of liver disease.
Leidner AJ, Chesson HW, Xu F, et al
Hepatology. 2015 Feb 11
Abstract

"Test, Listen, Cure" (TLC) Hepatitis C Community Awareness Campaign.
Coughlin SS.
JMIR Res Protoc. 2015 Feb 6;4(1):e13.
Abstract

Reasons for HCV non-treatment in underserved African Americans: Implications for treatment with new therapeutics.
Schaeffer S, Khalili M.
Ann Hepatol. 2015 Mar-Apr 2015;14(2):234-2
Abstract

A Window of Opportunity: Maximizing the Effectiveness of New HCV Regimens in the United States With the Expansion of the Affordable Care Act.
Haley SJ, Kreek MJ.
Am J Public Health. 2015 Jan 20:e1-e7
Abstract

Hepatitis C Virus Antibody Prevalence, Demographics and Associated Factors among Persons Screened at Hawai’i Community-based Health Settings, 2010-2013.
Takeuchi LC, Pham TK, Katz AR.
Hawaii J Med Public Health. 2015 Jan;74(1):9-15.
Abstract

FULL=TEXT ARTICLE
HIV and Hepatitis C Mortality in Massachusetts, 2002-2011: Spatial Cluster and Trend Analysis of HIV and HCV Using Multiple Cause of Death.
Meyers DJ, Hood ME, Stopka TJ.
PLoS One. 2014 Dec 11;9(12):e114822.
Paper

Provider Workforce Assessment in a Rural Hepatitis C Epidemic: Implications for Scale-up of Antiviral Therapy.
Westergaard RP, Stockman LJ, Hyland HA, et al
J Prim Care Community Health. 2014 Nov 24
Abstract

Utility of Evaluating HCV in an Uninsured Population.
Donepudi I, Paredes A, Hubbard S, et al
Dig Dis Sci. 2014 Nov 5
Abstract

Changes in characteristics of hepatitis C patients seen in a liver centre in the United States during the last decade.
Talaat N, Yapali S, Fontana RJ, et al
J Viral Hepat. 2014 Oct 14.
Abstract

Risk for Hepatitis B and C Virus Transmission in Nail Salons and Barbershops and State Regulatory Requirements to Prevent Such Transmission in the United States.
Yang J, Hall K, Nuriddin A, Woolard D.
J Public Health Manag Pract. 2014 November/December;20(6):E20-E30
Abstract

Age Cohort Differences in Illicit Drug Use and HCV among African American Substance Users.
Whitehead NE, Hearn L, Trenz RC, et al
J Addict Dis. 2014 Oct 9:0.
Abstract

Hospitalizations and costs associated with hepatitis C and advanced liver disease continue to increase.
Xu F, Tong X, Leidner AJ.
Health Aff (Millwood). 2014 Oct 1;33(10):1728-35.
Abstract

Impact of Completing Chronic Hepatitis C (CHC) Treatment on Post-Therapy Healthcare Cost.
Tandon N, Balart L, Laliberté F, et al
J Med Econ. 2014 Sep 12:1-26.
Abstract

Current Practices of Screening for Incident Hepatitis C Virus Infection among HIV- Infected, HCV-Uninfected Individuals in Primary Care.
Freiman JM, Huang W, White L, et al
Clin Infect Dis. 2014 Sep 3.
Abstract

Hepatitis C in African Americans.
Saab S, Jackson C, Nieto DO et al
Am J Gastroenterol. 2014 Sep 2.
Abstract

Unrecognized chronic hepatitis C virus infection among baby boomers in the emergency department.
Galbraith JW, Franco RA, Donnelly JP, et al
Hepatology. 2014 Sep 1
Abstract

Follow-up testing for hepatitis C virus infection: an analysis of Massachusetts surveillance data, 2007-2010.
Barton K, Church D, Onofrey S, Cocoros N, DeMaria A Jr
Public Health Rep. 2014 Sep;129(5):403-7.
Abstract

Comparison of hepatitis C virus testing strategies: birth cohort versus elevated alanine aminotransferase levels.
Smith BD, Yartel AK.
Am J Prev Med. 2014 Sep;47(3):233-41.
Abstract

Ending hepatitis C in the United States: the role of screening.
Coffin PO, Reynolds A.
Hepat Med. 2014 Jul 3;6:79-87.
Abstract

Impact of Race/Ethnicity and Gender on HCV Screening and Prevalence Among US Veterans in Department of Veterans Affairs Care.
Backus LI, Belperio PS, Loomis TP, Mole LA.
Am J Public Health. 2014 Sep;104 Suppl 4:S555-61.
Abstract

The changing burden of hepatitis C virus infection in the United States: model-based predictions.
Kabiri M, Jazwinski AB, Roberts MS, et al
Ann Intern Med. 2014 Aug 5;161(3):170-80.
Abstract

Medication use and medical comorbidity in patients with chronic hepatitis C from a US commercial claims database: high utilization of drugs with interaction potential.
Lauffenburger JC, Mayer CL, Hawke RL, et al
Eur J Gastroenterol Hepatol. 2014 Jul 10.
Abstract

Trends in HCV RNA testing among HCV antibody positive persons in care, 2003-2010.
Spradling PR, Tong X, Rupp L, et al
Clin Infect Dis. 2014 Jul 2
Abstract

Estimating the true prevalence of hepatitis C in Rhode Island.
Kinnard EN, Taylor LE, Galárraga O, Marshall BD.
R I Med J (2013). 2014 Jul 1;96(7):19-24
Abstract

HCV among The Miriam Hospital and Rhode Island Hospital Adult ED Patients.
Merchant RC, Baird JR, Liu T, Taylor LE.
R I Med J (2013). 2014 Jul 1;96(7):35-9.
Abstract

Substance use and hepatitis C: An ecological momentary assessment study.
Phillips KA, Epstein DH, Vahabzadeh M, et al
Health Psychol. 2014 Jul;33(7):710-9.
Abstract

A WEEK-IN-REVEW FEATURED REPORT
FULL TEXT ARTICLE
Higher risk of incident hepatitis C virus among young women who inject drugs compared with young men in association with sexual relationships: a prospective analysis from the UFO Study cohort.
Tracy D, Hahn JA, Fuller Lewis C, et al
BMJ Open. 2014 May 29;4(5):e004988
Paper

Inpatient resource utilization, disease severity, mortality and insurance coverage for patients hospitalized for hepatitis C virus in the United States.
Younossi ZM, Otgonsuren M, Henry L, et al
J Viral Hepat. 2014 May 12.
Abstract

FULL-TEXT ARTICLE
Expanding primary care capacity to treat hepatitis C virus infection through an evidence-based care model – Arizona and Utah, 2012-2014.
Mitruka K, Thornton K, Cusick S, et al
MMWR Morb Mortal Wkly Rep. 2014 May 9;63(18):393-8.
Paper

Hepatitis B Virus and Hepatitis C Virus Infections in United States-Bound Refugees from Asia and Africa.
Mixson-Hayden T, Lee D, Ganova-Raeva L
Am J Trop Med Hyg. 2014 Apr 14.
Abstract

FULL-TEXT ARTICLE
Rapid hepatitis C testing among persons at increased risk for infection – Wisconsin, 2012-2013.
Stockman LJ, Guilfoye SM, Benoit AL,
MMWR Morb Mortal Wkly Rep. 2014 Apr 11;63(14):309-11.
Paper

Racial Disparities in the Proportion of Current, Unresolved Hepatitis C Virus Infections in the United States, 2003-2010.
Liu G, Holmberg SD, Kamili S, Xu F.
Dig Dis Sci. 2014 Feb 27.
Abstract

Deaths among People with Hepatitis C in New York City, 2000 – 2011.
Pinchoff J, Drobnik A, Bornschlegel K, et al
Clin Infect Dis. 2014 Feb 12
Abstract

Hepatitis C screening trends in a large integrated health system.
Linas BP, Hu H, Barter DM, Horberg M.
Am J Med. 2014 Jan 28. pii: S0002-9343(14)00078-3
Abstract

Distinct Features in Natural History and Outcomes of Acute Hepatitis C.
Bunchorntavakul C, Jones LM, Kikuchi M, et al
J Clin Gastroenterol. 2014 Jan 27
Abstract

A pharmacist-managed telemedicine clinic for hepatitis C care: a descriptive analysis
You A, Kawamoto J, Smith JP.
J Telemed Telecare. 2014 Jan 10.
Abstract

Prevalence of Hepatitis C Virus Infection in US Hispanic/Latino Adults: Results from the NHANES 2007-2010 and HCHS/SOL Studies.
Kuniholm MH, Jung M, Everhart JE, et al
J Infect Dis. 2014 Jan 13
Abstract

The Spectrum of Undiagnosed Hepatitis C Virus Infection in a US HIV Clinic.
Taylor LE, Foont JA, Delong AK, et al
AIDS Patient Care STDS. 2014 Jan;28(1):4-9.
Abstract

HCV and HBV Testing Acceptability and Knowledge among Urban Emergency Department Patients and Pharmacy Clients.
Calderon Y, Cowan E, Schramm C, et al
Prev Med. 2013 Dec 29
Abstract

During chronic HCV infection NCR dependent NK cytolytic activity directed at HCV is associated with liver inflammation, African American Race, IL28B genotype and response to PegIFN/RBV therapy.
Meng Q, Rani MR, Sugalski JM, et al
J Infect Dis. 2013 Dec 2.
Abstract

Hepatitis C virus: An overview for dental health care providers.
Klevens RM, Moorman AC.
J Am Dent Assoc. 2013 Dec;144(12):1340-7.
Abstract

The Changing Epidemiology of Hepatitis C Virus Infection in the United States: National Health and Nutrition Examination Survey 2001 through 2010.
Ditah I, Ditah F, Devaki P, et al
J Hepatol. 2013 Nov 27.
Abstract
Awareness of Biologically Confirmed HCV Among a Community Residing Sample of Drug Users in Baltimore City.
Whitehead NE, Hearn LE, Marsiske M, et al
J Community Health. 2013 Oct 31.
Abstract

Less-Established Risk Factors Are Common in Asian Americans with Hepatitis C Virus: A Case-Controlled Study.
Kin KC, Lin B, Chaung KT, Ha NB, et al
Dig Dis Sci. 2013 Oct 1
Abstract
Characterization of hepatitis C infection in tuberculosis patients in an urban city in the USA.
Campo M, Shrestha A, Oren E, Thiede H, et al
Epidemiol Infect. 2013 Sep 25:1-8.
Abstract

Prevalence of HCV Infection Among Clients in Community-Based Health Settings in Hawaii, 2002-2010: Assessing Risk Factors.
Porter JC, Lusk HM, Katz AR.
Am J Public Health. 2013 Sep 12
Abstract
Many Patients with IL28B Genotypes Associated with Response to Therapy are Ineligible for Treatment Because of Comorbidities.
Kanwal F, White DL, Tavakoli-Tabasi S, et al
Clin Gastroenterol Hepatol. 2013 Aug 23.
Abstract

Hospitalizations due to hepatitis C in Los Angeles County, 2007-2009: case characteristics and factors associated with mortality.
Sie L, Gatto NM, Bancroft E.
J Viral Hepat. 2013 Sep;20(9):628-37.
Abstract

The Effect of Hepatitis C Treatment Response on Medical Costs: A Longitudinal Analysis in an Integrated Care Setting.
Manos MM, Darbinian J, Rubin J, et al
J Manag Care Pharm. 2013 July/August;19(6):438-447
Abstract

Perceptions of drug users regarding Hepatitis C screening and care: a qualitative study.
Jordan AE, Masson CL, Mateu-Gelabert P, et al
Harm Reduct J. 2013 Jun 20;10(1):10.
Abstract

Indications for Testing Among Reported Cases of Hepatitis C Virus Infection From Enhanced Hepatitis Surveillance Sites in the United States, 2004-2010.
Mahajan R, Liu SJ, Klevens RM, Holmberg SD.
AmJ Public Health. 2013 Jun 13
Abstract

FULL-TEXT PDF ARTICLE
Assessment of motivating factors associated with the initiation and completion of treatment for chronic hepatitis C virus (HCV) infection.
Fusfeld L, Aggarwal J, Dougher C, Vera-Llonch M, et al
BMC Infect Dis. 2013 May 23;13(1):234.
Paper

FULL-TEXT ARTICLE
Current and Future Disease Progression of the Chronic HCV Population in the United States.
Zalesak M, Francis K, Gedeon A, et al
PLoS One. 2013 May 21;8(5):e63959
Paper

FULL-TEXT ARTICLE
Vital signs: evaluation of hepatitis C virus infection testing and reporting – eight U, S.. Sites, 2005-2011.
Centers for Disease Control and Prevention (CDC).
MMWR Morb Mortal Wkly Rep. 2013 May 10;62(18):357-61.
Paper

Updates of Lifetime Costs of Care and Quality of Life Estimates for HIV-Infected Persons in the United States: Late Versus Early Diagnosis and Entry into Care.
Farnham PG, Gopalappa C, Sansom SL, et al
J Acquir Immune Defic Syndr. 2013 Apr 22
Abstract

Non-invasive serum fibrosis markers for screening and staging chronic hepatitis C virus (HCV) patients in a large U.S. cohort.
Holmberg SD, Lu M, Rupp LB, et al
Clin Infect Dis. 2013 Apr 16
Abstract

FULL-TEXT ARTICLE
Cost-effectiveness analysis of risk-factor guided and birth-cohort screening for chronic hepatitis C infection in the United States.
Liu S, Cipriano LE, Holodniy M, et al
PLoS One. 2013;8(3):e58975.
Paper

Predictors of alcohol use among rural drug users after disclosure of hepatitis C virus status.
Stephens DB, Havens JR.
J Stud Alcohol Drugs. 2013 May;74(3):386-95.
Abstract

The Hepatitis C Self-Management Program: Sustainability of Primary Outcomes at 1 Year.
Groessl EJ, Ho SB, Asch SM, et al
Health Educ Behav. 2013 Feb 27
Abstract

Cost-Effectiveness of Screening for Chronic Hepatitis C Infection in the United States.
Eckman MH, Talal AH, Gordon SC, et al
Clin Infect Dis. 2013 Feb
Abstract

Hepatitis Outreach Network: A Practical Strategy for Hepatitis Screening with Linkage to Care in Foreign Born communities.
Perumalswami PV, Factor SH, Kapelusznik L, et al
J Hepatol. 2013 Jan 15
Abstract

High Proportion of Hepatitis C Virus in Community Asian American Patients With Non-Liver-related Complaints.
Kin KC, Lin B, Ha NB, et al
J Clin Gastroenterol. 2012 Oct 18.
Abstract

The Impact of Ethnicity on Hepatitis C Virus Treatment Decisions and Outcomes.
Lisker-Melman M, Walewski JL.
Dig Dis Sci. 2012 Oct 12
Abstract

Distribution of hepatitis C virus genotypes in a diverse US integrated health care population.
Manos MM, Shvachko VA, Murphy RC, et al
J Med Virol. 2012 Nov;84(11):1744-50
Abstract

Knowledge, attitudes and barriers regarding vaccination against hepatitis A and B in patients with chronic hepatitis C virus infection: a survey of family medicine and internal medicine physicians in the United States.
Tenner CT, Herzog K, Chaudhari S,et al
Int J Clin Pract. 2012 Oct;66(10):1009-13.
Abstract

Patients’ Willingness to Accept the Risks and Benefits of New Treatments for Chronic Hepatitis C Virus Infection.
Kauf TL, Mohamed AF, Hauber AB, et al
Patient. 2012 Jul 10.
Abstract

Prevalence, distribution, and correlates of hepatitis C virus infection among homeless adults in Los Angeles.
Gelberg L, Robertson MJ, Arangua L, et al
Public Health Rep. 2012 Jul;127(4):407-21.
Abstract

Social networks and HCV viraemia in anti-HCV-positive rural drug users.
Young AM, Jonas AB, Havens JR.
Epidemiol Infect. 2012 Apr 19:1-10.
Abstract

An analysis of hepatitis C virus-related public inquiries from health professionals: 2009-2010.
Jorgensen CM, Lewis CA, Liu J.
Clin Infect Dis. 2012 Jul;55 Suppl 1:S54-7.
Abstract

Global burden of hepatitis C: considerations for healthcare providers in the United States.
Averhoff FM, Glass N, Holtzman D.
Clin Infect Dis. 2012 Jul;55 Suppl 1:S10-5.
Abstract

Evolving epidemiology of hepatitis C virus in the United States.
Klevens RM, Hu DJ, Jiles R, Holmberg SD.
Clin Infect Dis. 2012 Jul;55 Suppl 1:S3-9.
Abstract

The Burden of Untreated Hepatitis C Virus Infection: A US Patients’ Perspective.
El Khoury AC, Vietri J, Prajapati G.
Dig Dis Sci. 2012 Jun 5
Abstract

Health care-associated hepatitis C virus infections attributed to narcotic diversion.
Hellinger WC, Bacalis LP, Kay RS, et al
Ann Intern Med. 2012 Apr 3;156(7):477-82.
Abstract

Hepatitis C virus genotype distribution varies by underlying disease status among patients in the same geographic region: A retrospective multicenter study.
Torres HA, Nevah MI, Barnett BJ, et al
J Clin Virol. 2012 Mar 27.
Abstract

Economic burden of hepatitis C-associated diseases in the United States.
El Khoury AC, Klimack WK, Wallace C, Razavi H.
J Viral Hepat. 2012 Mar;19(3):153-60.
Abstract

Assessing educational needs of potential hepatitis C patients at a veterans affairs medical center.
Jennings AR.
Educ Health (Abingdon). 2011 Dec;24(3):532
Abstract

FULL-TEXT ARTICLE
Transmission of hepatitis C virus through transplanted organs and tissue – Kentucky and Massachusetts, 2011.
Centers for Disease Control and Prevention (CDC).
MMWR Morb Mortal Wkly Rep. 2011 Dec 23;60:1697-700
Paper

FULL-TEXT ARTCLE
Notes from the Field: Risk Factors for Hepatitis C Virus Infections Among Young Adults — Massachusetts, 2010
CDC
MMWR Morb Mortal Wkly Rep. 2011 Oct 28;60:1457-8.
Paper

Relationship between adherence to hepatitis C virus therapy and virologic outcomes: a cohort study
Lo Re V 3rd, Teal V, Localio AR, et al
Ann Intern Med. 2011 Sep 20;155(6):353-60.
Abstract

Public Health Implications of Rapid Hepatitis C Screening With an Oral Swab for Community-Based
Organizations Serving High-Risk Populations.
Drobnik A, Judd C, Banach D, et al
Am J Public Health. 2011 Sep 22.
Abstract

FULL-TEXT PDF ARTICLE
Temporal changes in HCV genotype distribution in three different high risk populations in San Francisco, California.
Telles Dias P, Hahn JA, Delwart E, et al
BMC Infect Dis. 2011 Aug 2;11(1):208
Paper

A WEEK-IN-REVIEW FEATURED REPORT
FULL-TEXT ARTICLE
Sexual Transmission of Hepatitis C Virus Among HIV-Infected Men Who Have Sex with Men —New York City, 2005–2010.
Centers for Disease Control and Prevention (CDC).
MMWR Morb Mortal Wkly Rep. 2011 Jul 22;60:945-50
Paper

Applying a system approach to forecast the total hepatitis C virus-infected population size: model validation using US data.
Kershenobich D, Razavi HA, Cooper CL, et al
Liver Int. 2011 Jul;31 Suppl 2:4-17.
Abstract

All-Cause, Liver-Related, and Non-Liver-Related Mortality Among HCV-Infected Individuals in the General US Population.
El-Kamary SS, Jhaveri R, Shardell MD.
Clin Infect Dis. 2011 Jun 10.
Abstract

Hepatitis C Virus Genotypes in Clinical Specimens Tested at a National Reference Testing Laboratory in the United States.
Germer JJ, Mandrekar JN, Bendel JL, et al
J Clin Microbiol. 2011 May 25
Abstract

Insurance status and treatment candidacy of hepatitis C patients: Analysis of population-based data from the United States.
Stepanova M, Kanwal F, El-Serag HB, Younossi ZM.
Hepatology. 2011 Mar;53(3):737-45
Abstract

Incident Hepatitis C Virus Infection among US HIV-Infected Men Enrolled in Clinical Trials.
Taylor LE, Holubar M, Wu K, et al
Clin Infect Dis. 2011 Jan 31
Abstract

Humanistic and economic impacts of hepatitis C infection in the United States.
Dibonaventura MD, Wagner JS, Yuan Y, et al
J Med Econ. 2010 Nov
Abstract

Barriers to accessing care in patients with chronic hepatitis C: the impact of depression.
Evon DM, Simpson KM, Esserman D, et al
Aliment Pharmacol Ther. 2010 Nov;32(9):1163-73.
Abstract

Expected increase in prevalence of HCV-related cirrhosis and its complications in the United States: No effect of current antiviral treatment coverage?
Deuffic-Burban S.
Gastroenterol Clin Biol. 2010 Nov 2
Abstract

FULL-TEXT ARTICLE
Evaluation of acute hepatitis C infection surveillance — United States, 2008.
Centers for Disease Control and Prevention (CDC).
MMWR Morb Mortal Wkly Rep. 2010 Nov 5;59(43):1407
Paper

Hepatitis C virus prevalence and clearance among US blood donors, 2006-2007: associations with birth cohort, multiple pregnancies, and body mass index.
Murphy EL, Fang J, Tu Y, et al
J Infect Dis. 2010 Aug 15;202(4):576-84
Abstract

Utilization and Antiviral Therapy in Patients with Chronic Hepatitis C:Analysis of Ambulatory Care Visits in the US.
Cheung R, Mannalithara A, Singh G.. et al
Dig Dis Sci. 2010 Feb 26.
Abstract

Health Care-Associated Transmission of Hepatitis B & C Viruses in Dental Care (Dentistry).
Younai FS.
Clin Liver Dis. 2010 Feb;14(1):93-104.
Abstract

Use of fax-back surveillance to determine epidemiologic and clinical characteristics of patients diagnosed with hepatitis C in Waterbury, Connecticut.
Sofair AN, Huie-White S, Stabach N, et al
Conn Med. 2009 Nov-Dec;73(10):593-5.
Abstract

Aging of the Hepatitis C Virus-Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease Progression.
Davis GL, Alter MJ, El-Serag H, et al
Gastroenterology. 2009 Oct 24
Abstract

Hepatitis C Virus Is Infrequently Evaluated and Treated in an Urban HIV Clinic Population.
Scott JD, Wald A, Kitahata M, et al
AIDS Patient Care STDS. 2009 Oct 14.
Abstract

Trends in Hepatitis C Virus Infection Among Patients in the HIV Outpatient Study, 1996-2007
Spradling PR, Richardson JT, Buchacz K, et al
J Acquir Immune Defic Syndr. 2009 Sep 4
Abstract

FULL-TEXT ARTICLE
Population-based surveillance for hepatitis C virus, United States, 2006–2007.
Klevens RM, Miller J, Vonderwahl C, et al
Emerg Infect Dis]. 2009 Sep
Abstract

Prevalence of Hepatitis C Infection in New York City, 2004.
Bornschlegel K, Berger M, Garg RK, et al
J Urban Health. 2009 Aug 12
Abstract

Hepatitis C Virus Transmission in Hemodialysis Units: Importance of Infection
Control Practices and Aseptic Technique.
Thompson ND, Novak RT, Datta D, et al
Infect Control Hosp Epidemiol. 2009 Jul 30
Abstract

Undiagnosed hepatitis C on the general medicine and trauma services of two urban hospitals.
Brady KA, Weiner M, Turner BJ.
J Infect. 2009 May 3
Abstract

Hepatitis C: experiencing stigma.
Moore GA, Hawley DA, Bradley P.
Gastroenterol Nurs. 2009 Mar-Apr;32(2):94-104.
Abstract

A meta-analysis of the hepatitis C virus distribution in diverse racial/ethnic drug injector groups.
Lelutiu-Weinberger C, Pouget ER, Des Jarlais DD, et al.
Soc Sci Med. 2008 Dec 3
Abstract

Guideline-concordant hepatitis C virus testing and notification among patients with and without
mental disorders.
Kilbourne AM, McCarthy JF, Himelhoch S, et al
Gen Hosp Psychiatry. 2008 Nov-Dec;30(6):495-500
Abstract

Hepatitis C is a predictor of acute liver injury among hospitalizations for acetaminophen overdose in the United States: A nationwide analysis.
Nguyen GC, Sam J, Thuluvath PJ.
Hepatology. 2008 Jul 23;48(4):1336-1341.
Abstract

FULL TEXT PDF ARTICLE
Acute Hepatitis C Virus Infections Attributed to Unsafe Injection Practices at an Endoscopy Clinic — Nevada, 2007
Centers for Disease Control and Prevention (CDC).
MMWR Morb Mortal Wkly Rep. 2008 May 16;57(19):517-21
Paper

Changing trends in hepatitis C-related mortality in the United States, 1995-2004.
Wise M, Bialek S, Finelli L, et al
Hepatology. 2007 Dec 19
Abstract

Chronic Hepatitis C in the Hispanic/Latino Population Living in the United States: A Literature Review.
Blessman DJ.
Gastroenterol Nurs. 2008 January/February;31(1):17-25.
Abstract

Acute Hepatitis C in a Contemporary US Cohort: Modes of Acquisition and Factors Influencing Viral Clearance.
Wang CC, Krantz E, Klarquist J, et al
J Infect Dis. 2007 Nov 15;196(10):1474-1482
Abstract

The epidemiology of hepatitis C infection in the United States.
Rustgi VK.
J Gastroenterol. 2007 Jul;42(7):513-21.
Abstract

Hepatitis-C prevalence in an urban native-American clinic: a prospective screening study.
Neumeister AS, Pilcher LE, Erickson JM, et al
J Natl Med Assoc. 2007 Apr;99(4):389-92.
Abstract

Alcohol and hepatitis C mortality among males and females in the United States: a life table analysis.
Chen CM, Yoon YH, Yi HY, Lucas DL.
Alcohol Clin Exp Res. 2007 Feb;31(2):285-92
Abstract
.

The emerging importance of chronic hepatitis C infection in asian americans.
Cheng JT, Hsien C, Josh Sun HE, Tong MJ.
Am J Gastroenterol. 2006 Dec;101(12):2737-43
Abstract

The prevalence of hepatitis C virus infection in the United States, 1999 through 2002.
Arstrong GL, Wasley A, Simard EP
Ann Intern Med. 2006 May 16;144(10):705-14
Abstract

     Conference Reports, Abstracts, and Posters

District of Columbia Partnership for HIV/AIDS Progress (DC PFAP) Subspecialty Clinics: a model for hepatitis C care and research in community clinics serving a predominantly HIV-positive population
Z. Moak, D. Silver, A. Osinusi, et al
(XIX International AIDS Conference)
Abstract

HCV Epidemiology Main Page Main New/Newsworthy Home Page

National Seroprevalence/Incidence Studies
National Challenges